Havemeyer Place LP Makes New Investment in Albemarle Corporation $ALB

Posted by on Jun 8th, 2026

Havemeyer Place LP purchased a new position in shares of Albemarle Corporation (NYSE:ALB – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 6,526 shares of the specialty chemicals company’s stock, valued at approximately $923,000.

Other institutional investors also recently bought and sold shares of the company. MH & Associates Securities Management Corp ADV purchased a new position in Albemarle during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC purchased a new position in Albemarle during the 4th quarter worth approximately $34,000. Torren Management LLC purchased a new position in Albemarle during the 4th quarter worth approximately $38,000. Root Financial Partners LLC raised its position in Albemarle by 121.5% during the 4th quarter. Root Financial Partners LLC now owns 299 shares of the specialty chemicals company’s stock worth $42,000 after buying an additional 164 shares during the last quarter. Finally, Strategic Advocates LLC purchased a new position in Albemarle during the 3rd quarter worth approximately $25,000. 92.87% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Albemarle

In related news, CEO J Kent Masters sold 16,393 shares of Albemarle stock in a transaction on Friday, May 15th. The shares were sold at an average price of $183.72, for a total value of $3,011,721.96. Following the sale, the chief executive officer owned 87,519 shares of the company’s stock, valued at approximately $16,078,990.68. This trade represents a 15.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.42% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the stock. Wall Street Zen raised shares of Albemarle from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 23rd. Truist Financial raised their price target on shares of Albemarle from $245.00 to $260.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Bank of America raised their price target on shares of Albemarle from $190.00 to $225.00 and gave the stock a “buy” rating in a research report on Tuesday, April 21st. Mizuho raised their price objective on shares of Albemarle from $185.00 to $205.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Finally, Argus raised their price objective on shares of Albemarle from $185.00 to $230.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $203.04.

View Our Latest Research Report on ALB

Albemarle Price Performance

Shares of NYSE ALB opened at $155.73 on Monday. The stock has a market capitalization of $18.37 billion, a price-to-earnings ratio of -45.67, a PEG ratio of 0.78 and a beta of 1.31. Albemarle Corporation has a 12 month low of $55.90 and a 12 month high of $221.00. The firm’s 50 day simple moving average is $183.54 and its 200-day simple moving average is $166.10. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.07 and a quick ratio of 1.21.

Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The specialty chemicals company reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $1.71. The business had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.34 billion. Albemarle had a negative net margin of 5.00% and a positive return on equity of 5.22%. The business’s revenue was up 32.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.18) EPS. Analysts expect that Albemarle Corporation will post 12.39 EPS for the current year.

Albemarle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Friday, June 12th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, June 12th. This represents a $1.62 dividend on an annualized basis and a yield of 1.0%. Albemarle’s dividend payout ratio (DPR) is currently -47.51%.

Albemarle Company Profile

(Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.

Featured Articles

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.